Cargando…
A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS
BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859310/ http://dx.doi.org/10.1093/jcag/gwab049.022 |
_version_ | 1784654429151035392 |
---|---|
author | El-Matary, W Witt, J Bernstein, C N Jacobson, K Mack, D R Otley, A Walters, T Huynh, H Q deBruyn, J Griffiths, A Benchimol, E I |
author_facet | El-Matary, W Witt, J Bernstein, C N Jacobson, K Mack, D R Otley, A Walters, T Huynh, H Q deBruyn, J Griffiths, A Benchimol, E I |
author_sort | El-Matary, W |
collection | PubMed |
description | BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect and out of pocket (OOP) pediatric IBD-associated costs in Canada. METHODS: In a nation-wide cross-sectional analysis, caregivers of children and young adults (<17 years) with IBD were invited to complete a questionnaire on lost work hours and OOP costs related to IBD in the 4 weeks prior to the survey. Participants were re-invited to periodically answer the same questionnaire every 3–9 months for 2 years. Lost productivity was calculated using the Human Capital method. Costs were reported in 2018 inflation-adjusted Canadian dollars. Predictors of high cost users (top 25%) were examined using negative binomial regression. RESULTS: Consecutive 243 (82 incident cases) of 262 (92.7%) approached participants completed the first survey with a total of 450 surveys longitudinally completed over 2 years. The annual median indirect costs per patient were $5,951 (IQR $1,812- $12,278), with $5,776 (IQR $1,465-$11,733) for Crohn’s disease (CD) and $6,084 (IQR $2,470-$13,371) for ulcerative colitis (UC) (p=0.77). The annual median per patient OOP costs were $2,925 (IQR $978- $8,125) with $3,021 (IQR $978- $8,125) for CD and $2,600 (IQR $975- $8,125) for UC (p=0.55). Older age (10-17y) at diagnosis (p=0.04) and parents in part-time employment (p=0.01) were predictors of higher indirect costs, while female sex (p<0.001), parents with a lower education level (p<0.001) and lower annual family income (p<0.01) were associated with higher OOP costs. CONCLUSIONS: Indirect and OOP IBD-associated costs are substantial and more likely to affect families with unstable employment and lower annual income. Examining different strategies and interventions to reduce these costs such as virtual platforms, telephone and outreach clinics especially in poor communities and families with low annual income is warranted. FUNDING AGENCIES: CIHRThe Children’s Hospital Research Institute of Manitoba |
format | Online Article Text |
id | pubmed-8859310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88593102022-02-22 A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS El-Matary, W Witt, J Bernstein, C N Jacobson, K Mack, D R Otley, A Walters, T Huynh, H Q deBruyn, J Griffiths, A Benchimol, E I J Can Assoc Gastroenterol Poster of Distinction BACKGROUND: Identifying disease-related costs is a crucial step to plan for proper allocation of resources and future healthcare services for persons with inflammatory bowel disease (IBD). Data on pediatric inflammatory bowel disease-associated costs are limited. AIMS: We aimed to estimate indirect and out of pocket (OOP) pediatric IBD-associated costs in Canada. METHODS: In a nation-wide cross-sectional analysis, caregivers of children and young adults (<17 years) with IBD were invited to complete a questionnaire on lost work hours and OOP costs related to IBD in the 4 weeks prior to the survey. Participants were re-invited to periodically answer the same questionnaire every 3–9 months for 2 years. Lost productivity was calculated using the Human Capital method. Costs were reported in 2018 inflation-adjusted Canadian dollars. Predictors of high cost users (top 25%) were examined using negative binomial regression. RESULTS: Consecutive 243 (82 incident cases) of 262 (92.7%) approached participants completed the first survey with a total of 450 surveys longitudinally completed over 2 years. The annual median indirect costs per patient were $5,951 (IQR $1,812- $12,278), with $5,776 (IQR $1,465-$11,733) for Crohn’s disease (CD) and $6,084 (IQR $2,470-$13,371) for ulcerative colitis (UC) (p=0.77). The annual median per patient OOP costs were $2,925 (IQR $978- $8,125) with $3,021 (IQR $978- $8,125) for CD and $2,600 (IQR $975- $8,125) for UC (p=0.55). Older age (10-17y) at diagnosis (p=0.04) and parents in part-time employment (p=0.01) were predictors of higher indirect costs, while female sex (p<0.001), parents with a lower education level (p<0.001) and lower annual family income (p<0.01) were associated with higher OOP costs. CONCLUSIONS: Indirect and OOP IBD-associated costs are substantial and more likely to affect families with unstable employment and lower annual income. Examining different strategies and interventions to reduce these costs such as virtual platforms, telephone and outreach clinics especially in poor communities and families with low annual income is warranted. FUNDING AGENCIES: CIHRThe Children’s Hospital Research Institute of Manitoba Oxford University Press 2022-02-21 /pmc/articles/PMC8859310/ http://dx.doi.org/10.1093/jcag/gwab049.022 Text en ڣ The Author(s) 2022. Published by Oxford University Press on behalf of the Canadian Association of Gastroenterology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster of Distinction El-Matary, W Witt, J Bernstein, C N Jacobson, K Mack, D R Otley, A Walters, T Huynh, H Q deBruyn, J Griffiths, A Benchimol, E I A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title | A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title_full | A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title_fullStr | A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title_full_unstemmed | A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title_short | A23 ESTIMATING INDIRECT AND OUT-OF-POCKET COSTS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE: A NATION-WIDE CROSS-SECTIONAL ANALYSIS |
title_sort | a23 estimating indirect and out-of-pocket costs in pediatric inflammatory bowel disease: a nation-wide cross-sectional analysis |
topic | Poster of Distinction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859310/ http://dx.doi.org/10.1093/jcag/gwab049.022 |
work_keys_str_mv | AT elmataryw a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT wittj a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT bernsteincn a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT jacobsonk a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT mackdr a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT otleya a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT walterst a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT huynhhq a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT debruynj a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT griffithsa a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis AT benchimolei a23estimatingindirectandoutofpocketcostsinpediatricinflammatoryboweldiseaseanationwidecrosssectionalanalysis |